Edwards Sapien 3 TAVI Granted European Approval to Treat Low-risk Patients

Nov 6, 2019 | DAIC Articles

Edwards Lifesciences announced it received European CE mark to expand use of the Edwards Sapien 3 transcatheter aortic valve replacement (TAVR) device for the treatment of patients diagnosed with aortic stenosis who are at low risk for open-heart surgery.

X